High Levels of Endothelin (ET)-1 and Aneurysm Diameter Independently Predict Growth of Stable Abdominal Aortic Aneurysms

Abstract

The etiology of abdominal aortic aneurysm (AAA) includes inflammation and endothelial dysfunction. To evaluate relations between these mechanisms and AAA growth, endothelin (ET)-1, tumor necrosis factor (TNF)-α, interleukin (IL)-6, and CD40 ligand were related to yearly AAA growth for 2.9 ± 1.6 years (mean ± SD) in 178 patients with conservatively followed AAA. Total number of follow-up years was 491. Abdominal aortic aneurysm diameter increased by 3.3 ± 4.0 mm during the first year and by 4.9 ± 4.4 mm during the first 2 years. Median (range) growth was 2.5 (—1.0 to 30.6) mm/year. When patients with AAA growth above or below median were compared, initial AAA diameter (46.1 ± 5.8 vs 42.0 ± 8.3 mm; P < .0001), age (75 ± 7 vs 72 ± 8 years; P < .029), and initial ET-1 levels (1.31 ± 0.50 vs 1.13 ± 0.49 pg/mL; P < .0177) were higher in patients with growth above median. Endothelin 1 (P = .0230) and initial AAA diameter (P = .0019) predicted AAA growth above median in logistic regression. In conclusion, higher initial levels of ET-1 and initial AAA diameter independently predict AAA growth.

Keywords

abdominal aortic aneurysm growth endothelin 1 statin inflammation tumor necrosis factor α interleukin 6 CD40 ligand

Get full access to this article

View all access options for this article.

References

Wassef M. , Baxter BT , Chisholm RL , et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute . J Vasc Surg. 2001;34(4):730-738.

Vainas T. , Lubbers T. , Stassen FR , et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation. 2003;107(8): 1103-1105.

Lindblad B. , Börner G. , Gottsäter A. Factors associated with development of large abdominal aortic aneurysm in middle-aged men. Eur J Vasc Endovasc Surg. 2005;30(4):346-352.

Lindholt JS , Shi G. - P. Chronic inflammation, immune response and infection in abdominal aortic aneurysms . Eur J Vasc Endovasc Surg. 2006;31(5):453-463.

Golledge J. , Muller J. , Daugherty A. , Norman P. Abdominal aortic aneurysm pathogenesis and implications for management . Art Thromb Vasc Biol. 2006;26(12):2605-2619.

Schlösser FJV , Tangelder MJD , Verhagen HJM , et al. Growth predictors and prognosis of small abdominal aortic aneurysms. J Vasc Surg. 2008;47(6):1127-1133.

Urbonavicius S. , Urbonaviciene G. , Honoré B. , Henneberg EW , Vorum H. , Lindholt JS Potential circulating biomarkers for abdominal aortic aneurysm expansion and rupture - a systematic review. Eur J Vasc Endovasc Surg. 2008;36(3):273-280.

Middleton RK , Lloyd GM , Bown MJ , Cooper NJ , London NJ , Sayers RD The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: a protein array study . J Vasc Surg. 2007;45(3):574-580.

Hamano K. , Li TS , Takahashi M. , et al. Enhanced tumor necrosis factor-alpha expression in small sized abdominal aortic aneurysms. World J Surg. 2003;27(4):476-480.

10.

Dawson J. , Cockerhill GW , Choke E. , Belli AM , Loftus I. , Thompson MM Aortic aneurysms secrete interleukin-6 into the circulation. J Vasc Surg. 2007;45(2):350-356.

11.

Kishimoto T. The biology of interleukin-6. Blood. 1989;74(1): 1-10.

12.

Kälsch T. , Nguyen XD , Elmas E. , et al. Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina. Int J Cardiol. 2006;111(2):217-223.

13.

Schönbeck U. , Libby P. CD40 signaling and plaque instability . Circ Res. 2001;89(12):1092-1103.

14.

Schönbeck U. , Gerdes N. , Varo N. , et al. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. Circulation . 2002;106(23):2888-2893.

15.

Newby DE , Webb DJ The endothelin system in cardiovascular disease. BMJ. 1997;314(7080):531-532.

16.

Ikeda U. , Yamamoto K. , Maeda Y. , Shimpo M. , Kanbe T. , Shimada K. Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells . Hypertension. 1997;29(1 pt 1):65-69.

17.

Třeška V. , Wenham PJ , Valenta J. , Topolčan O. , Pecen L. Plasma endothelin levels in patients with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 1999;17(5):424-428.

18.

Wagner A. , Domanovits H. , Holzer M. , et al. Plasma endothelin in patients with acute aortic disease. Resuscitation. 2002;53(1):71-76.

19.

Schouten O. , van Laanen JH , Boersma E. , Vidakovic R. , Feringa HH , Dunkelgrun M. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg . 2006;32(1):21-26.

20.

Golledge J. , Karan M. , Moran CS , et al. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. Eur Heart J. 2008;29(5):665-672.

21.

Barton M. Endothelial dysfunction and atherosclerosis: endothelin receptor antagonists as novel therapeutics. Curr Hypertens Rep. 2000;2(1):84-91.

22.

Adam DJ , Evans SM , Webb DJ , Bradbury AW Plasma endothelin levels and outcome in patients undergoing repair of ruptured infrarenal abdominal aortic aneurysms. J Vasc Surg. 2001;33(6): 1242-1246.

23.

Solberg S. , Singh K. , Wilsgaard T. , Jacobsen BK Increased growth rate of abdominal aortic aneurysms in women The Tromsø study. Eur J Vasc Endovasc Surg. 2005;29(2):145-149.

24.

Brady AR , Thompson SG , Fowkes FG , Greenhalgh RM , Powell JT Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance . Circulation. 2004;110(1): 16-21.

25.

Brown PM , Sobolev B. , Zelt DT Selective management of abdominal aortic aneurysms smaller than 5.0 cm in a prospective sizing program with gender-specific analysis. J Vasc Surg. 2003;38(4):762-765.

26.

Gottsäter A. , Flondell-Sité D. , Kölbel T. , Lindblad B. Associations between statin treatment and markers of inflammation, vasoconstriction and coagulation in patients with abdominal aortic aneurysm. Vasc Endovasc Surg. 2009;42(6):567-573.

27.

Sukhija R. , Aronow WS , Sandhu R. , Kakar P. , Babu S. Mortality and size of abdominal aortic aneurysm at long term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol. 2006;97(2):279-280.

28.

Bigatel DA , Elmore JR , Carey DJ , Cizmeci-Smith G. , Franklin DP , Youkey JR The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J Vasc Surg. 1999 ;29(1):130-138.

29.

Thompson RW , Baxter T. MMP inhibition in abdominal aortic aneurysms: rationale for a prospective randomized clinical trial. Ann NY Acad Sci. 1999;878(1):159-178.

30.

Nagashima H. , Aoka Y. , Sakomura Y. , et al. Matrix metalloproteinase 2 is suppressed by trapidil, a CD40-CD40 ligand pathway inhibitor, in human abdominal aortic aneurysm wall. J Vasc Surg. 2004;39(2):447-453.

31.

Barton M. , Yanagisawa M. Endothelin: 20 years from discovery to therapy. Can J Physiol Pharmacol. 2008;86(8):485-498.

32.

Pearl JD , Macdonald RL Clazosentan reduced angiographic vasospasm in a dose-dependent manner in patients with aneurysmal SAH following coiling or clipping of the aneurysm . Acta Neurochir. 2008;105(suppl. 00651419):207-210.